Predictors for Remission of Major Components of the Metabolic Syndrome After Biliopancreatic Diversion with Duodenal Switch (BPDDS)
- 26 September 2012
- journal article
- Published by Springer Science and Business Media LLC in Obesity Surgery
- Vol. 23 (1), 80-86
- https://doi.org/10.1007/s11695-012-0775-0
Abstract
Metabolic surgery causes the remission of type 2 diabetes mellitus (T2DM), hypertension, and hyperlipidemia to varying degrees, depending on the patient characteristics and the surgical procedure. The aim of this study was to find predictors for the remission of T2DM and hypertension after biliopancreatic diversion with duodenal switch (BPDDS). Eighty patients with T2DM were followed up for 2 years or more after BPDDS, and changes in body weight and metabolic status were noted. Remission was defined as fasting glucose 2, and duration of diabetes was 5 years. Of the 80 patients, 38 patients were using insulin, 48 patients were using antihypertensives, and 38 patients were using a lipid-lowering drug. Five percent of the patients had recommended levels for HbA1C, blood pressure, and LDL prior to the operation. The remission rate at 2 years was 94 % for T2DM, 54 % for hypertension, and 86 % for LDL hyperlipidemia. Preoperative predictors for nonremission of T2DM were a higher BMI, insulin usage, and low insulin C-peptide, and for hypertension, older age and more severe hypertension. Postoperative weight loss was important for both. Surgical intervention with BPDDS is an effective treatment of T2DM, hypertension, and hyperlipidemia. The duration of T2DM and age of the patient are the most important preoperative predictors for the remission of T2DM and hypertension, respectively.Keywords
This publication has 35 references indexed in Scilit:
- Ten-year duration of type 2 diabetes as prognostic factor for remission after sleeve gastrectomySurgery for Obesity and Related Diseases, 2011
- Bariatric surgery: an IDF statement for obese Type 2 diabetesDiabetic Medicine, 2011
- Effects of Bilio-Pancreatic Diversion on Diabetic ComplicationsDiabetes Care, 2011
- Standards of Medical Care in Diabetes—2011Diabetes Care, 2011
- Diabetes: cost of illness in NorwayBMC Endocrine Disorders, 2010
- Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypassSurgery for Obesity and Related Diseases, 2010
- How Do We Define Cure of Diabetes?Diabetes Care, 2009
- Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and WomenArchives of Internal Medicine, 2004
- Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes MellitusAnnals of Surgery, 2003
- Amelioration of Diabetes Mellitus Following Gastric ResectionActa Medica Scandinavica, 1961